137 related articles for article (PubMed ID: 10346914)
1. A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.
Hockin MF; Cawthern KM; Kalafatis M; Mann KG
Biochemistry; 1999 May; 38(21):6918-34. PubMed ID: 10346914
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain.
Mann KG; Hockin MF; Begin KJ; Kalafatis M
J Biol Chem; 1997 Aug; 272(33):20678-83. PubMed ID: 9252387
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
4. Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses.
Orban T; Kalafatis M; Gogonea V
Biochemistry; 2005 Oct; 44(39):13082-90. PubMed ID: 16185076
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
6. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.
Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J
J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
Kalafatis M; Rand MD; Mann KG
J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
[TBL] [Abstract][Full Text] [Related]
9. Role of the membrane in the inactivation of factor Va by activated protein C.
Kalafatis M; Mann KG
J Biol Chem; 1993 Dec; 268(36):27246-57. PubMed ID: 8262965
[TBL] [Abstract][Full Text] [Related]
10. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
Egan JO; Kalafatis M; Mann KG
Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
[TBL] [Abstract][Full Text] [Related]
11. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.
Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH
Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065
[TBL] [Abstract][Full Text] [Related]
12. The effect of membrane composition on the hemostatic balance.
Smirnov MD; Ford DA; Esmon CT; Esmon NL
Biochemistry; 1999 Mar; 38(12):3591-8. PubMed ID: 10090745
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional model of coagulation factor Va bound to activated protein C.
Pellequer JL; Gale AJ; Getzoff ED; Griffin JH
Thromb Haemost; 2000 Nov; 84(5):849-57. PubMed ID: 11127867
[TBL] [Abstract][Full Text] [Related]
14. Coagulation factor V: an old star shines again.
Rosing J; Tans G
Thromb Haemost; 1997 Jul; 78(1):427-33. PubMed ID: 9198191
[TBL] [Abstract][Full Text] [Related]
15. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
16. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.
Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G
J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
[TBL] [Abstract][Full Text] [Related]
18. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
Hockin MF; Kalafatis M; Shatos M; Mann KG
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
[TBL] [Abstract][Full Text] [Related]
19. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
Smirnov MD; Safa O; Regan L; Mather T; Stearns-Kurosawa DJ; Kurosawa S; Rezaie AR; Esmon NL; Esmon CT
J Biol Chem; 1998 Apr; 273(15):9031-40. PubMed ID: 9535891
[TBL] [Abstract][Full Text] [Related]
20. Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex.
Koppaka V; Talbot WF; Zhai X; Lentz BR
Biophys J; 1997 Nov; 73(5):2638-52. PubMed ID: 9370458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
